Kolexia
Collin Gilles Médecine générale
Collin Gilles
Médecine générale
Chm
Mamoudzou, France
53 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections à VIH COVID-19 Infections à papillomavirus Infections à coronavirus Co-infection Pneumopathie virale Carcinome épidermoïde Tumeurs de l'amygdale Érythème pernio

Collaborateurs

Voir plus
Descamps Diane
Descamps Diane
Hôpital Bichat-Claude-Bernard, Paris, France
Charpentier Charlotte
Charpentier Charlotte
Hôpital Bichat-Claude-Bernard, Paris, France
Visseaux Benoit
Visseaux Benoit
Lbm Selafa Cerba Site Frepillon, Saint-Ouen-l'Aumône, France
Matheron Sophie
Matheron Sophie
Hôpital Bichat-Claude-Bernard, Paris, France

Industries

Voir plus
{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Temporal dynamics of RSV shedding and genetic diversity in adults during the COVID-19 pandemic in a French hospital, early 2021.
Virus research   29 septembre 2022
Mutations in the 3'-PPT Lead to HIV-1 Replication without Integration.
Journal of virology   27 juin 2022
Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays.
The Journal of infection   10 mars 2022
Ibalizumab shows in-vitro activity against group A and group B HIV-2 clinical isolates.
AIDS (London, England)   07 mars 2022
In vitro analysis of the replicative capacity and phenotypic susceptibility to integrase inhibitors of HIV-2 mutants with integrase insertions.
The Journal of antimicrobial chemotherapy   03 mars 2022
Earlier Viral Production With SARS-CoV-2 Alpha Than With Beta, Gamma, B, or A.27 Variants.
Frontiers in cellular and infection microbiology   16 décembre 2021
Alpha (B.1.1.7) and Delta (B.1.617.2 - AY.40) SARS-CoV-2 variants present strong neutralization decay at M4 post-vaccination and a faster replication rates than D614G (B.1) lineage.
The Journal of infection   19 novembre 2021
Efficacy of Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine in Patients With Thoracic Cancer: A Prospective Study Supporting a Third Dose in Patients With Minimal Serologic Response After Two Vaccine Doses.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer   16 novembre 2021
Humoral Response Induced by Prime-Boost Vaccination with the ChAdOx1 nCoV-19 and mRNA BNT162b2 Vaccines in a Teriflunomide-Treated Multiple Sclerosis Patient.
Vaccines   06 octobre 2021
Decreasing humoral response among healthcare workers up to 4 months after two doses of BNT162b2 vaccine.
The Journal of infection   29 septembre 2021